Pre-aggregated Aβ1-42 peptide increases tau aggregation and hyperphosphorylation after short-term application.
Neuritic amyloid plaques and neurofibrillary tangles, consisting of hyperphosphorylated tau protein, are the hallmarks of Alzheimer disease. It is not clear so far, how both structures are functionally and physiologically connected. We have investigated the role of Aβ1-42 on hyperphosphorylation and aggregation of tau in SY5Y cells by transfection and overexpression with two tau constructs, a shortened wildtype tau (2N4R) and a point mutation tau (P301L), found in fronto-temporal dementia. It was found that the tau protein becomes hyperphosphorylated and forms large aggregates inside cells, visualized by immunofluorescence, after short incubation of 90 min with preaggregated Aβ1-42. In Addition, Aβ1-42 caused a decrease of tau solubility in both tau constructs in this relatively short time period. Taken together, these experiments suggest that pathological preaggregated Aβ1-42 in physiological concentrations quickly induces hyperphosphorylation and pathological structural changes of tau protein and thereby directly linking the 'amyloid hypothesis' to tau pathology, observed in Alzheimer disease.
Department of Psychiatry and Psychotherapy, University Hospital of Erlangen, Erlangen, Germany.
Sabine
S
Ott
Andreas Wolfram
AW
Henkel
Maria Kerstin
MK
Henkel
Zoran B
ZB
Redzic
Johannes
J
Kornhuber
Jens
J
Wiltfang
D016229:Amyloid beta-Peptides / Q000494:pharmacology*; D002460:Cell Line; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D010446:Peptide Fragments / Q000494:pharmacology*; D010766:Phosphorylation; D017354:Point Mutation; D055550:Protein Stability; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000235:genetics; D012995:Solubility; D016875:tau Proteins / Q000096:biosynthesis* / Q000235:genetics
D016229:Amyloid beta-Peptides; D010446:Peptide Fragments; D011994:Recombinant Proteins; C075222:amyloid beta-protein (1-42); D016875:tau Proteins; D007770:L-Lactate Dehydrogenase